menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Biosynth Appoints Matt Gunnison as CEO, Kieran Murphy as Chairman

    BUSINESSWIRE

    Biosynth Opens Cutting-Edge Facility at Lifebay in Suzhou, China

    BUSINESSWIRE

    VIO Biosynth rebrands to Biosynth

    PRESS RELEASE

    FDA GMP and Global ISO Inspections successful for Biosynth

    PRESS RELEASE

    Biosynth to Offer Complex Chemistry Solutions at Greater Scales

    BUSINESSWIRE

    Biosynth extends its offering to multi-kilogram GMP peptide synthesis

    BUSINESSWIRE

    Biosynth Expands Capabilities with Acquisition of celares

    BUSINESSWIRE

    Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge

    BUSINESSWIRE

    Biosynth Carbosynth Expands Peptide Offering with Acquisition of Pepscan

    BUSINESSWIRE

    Biosynth Carbosynth Expands Life Sciences Platform; Acquires Aalto Bio Reagents

    BUSINESSWIRE

    Sense, Cruinn Diagnostics Sign Distribution Agreement to Market Veros COVID-19

    BUSINESSWIRE

    Biosynth & Shengquan acquire new plant to increase production capacities China

    EXPRESSPHARMA

    Biosynth Carbosynth & Shengquan Acquire Factory from Kexing Biopharmaceutical

    CONTRACTPHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.